マーケットレポート詳細
肝炎検査・診断の世界市場：肝炎タイプ別、技術別2026年予測
Hepatitis Testing/Diagnosis Market by Disease Type (Hepatitis B, Hepatitis C, Other Hepatitis), Technology (ELISA, RDT, PCR, INAAT), End User (Hospitals, Diagnostic Laboratories, Blood Banks), and Region - Global Forecast to 2026
- 出版元：MarketsandMarkets
出版元について - 発行年：2021年11月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文175ページになります。
- 商品コード：MAM2764
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
肝炎検査・診断の世界市場規模は2021年で28億ドル、2026年には36億ドルへと拡大し、市場の平均年成長率は4.7%に達する見込みです。
肝炎検査・診断市場の成長要因は、肝炎罹患の負担の重さ、輸血/献血の増加、ポイントオブケア(POC)装置/キットの恩恵、肝炎に関する認知度向上への取り組み、などが挙げられます。セグメント別市場では、技術別でELISAが予測期間中に最も高いシェアを保持しています。
レポートは肝炎検査・診断の世界市場について2026年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（疾患タイプ別市場、技術別市場、等）を中心に構成されています。また競合状況、主要企業情報（10社）、COVID-19による肝炎検査・診断市場への影響、市場シェア分析などの分析も加味し、肝炎検査・診断市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆肝炎検査・診断の世界市場予測2018-2026年
・市場規模(US$)
◆疾患タイプ別、市場-2026年
・B型肝炎(HBV)
・C型肝炎(HCV)
・その他肝炎疾患
※(市場規模US$)
◆技術別、市場-2026年
・酵素結合免疫吸着測定法(ELISA)
・迅速診断検査(RDT)
・ポリメラーゼ連鎖反応(PCR)
・等温核酸増幅技術(INAAT)
・その他技術
※(市場規模US$)
◆エンドユーザー別、市場-2026年
・病院/診断ラボラトリーズ
・血液銀行
・その他エンドユーザー
※(市場規模US$)
◆主要国地域別市場-2026年
北米
・米国、カナダ
欧州
・ドイツ、英国
・その他欧州
アジア太平洋
その他地域
※国地域別に全セグメント別の細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス（ドライバー、障壁、機会、課題）
・COVID-19による肝炎検査・診断市場への影響
・市場シェア分析
・競合状況
◆肝炎検査・診断の主要企業プロフィール動向
・ABBOTT LABORATORIES
・F. HOFFMANN-LA ROCHE LTD.
・BIO-RAD LABORATORIES, INC.
・SIEMENS HEALTHINEERS AG
・DIASORIN S.P.A
・QIAGEN
・DANAHER CORPORATION
・GRIFOLS, S.A.
・BIOMÉRIEUX SA
・ORTHO CLINICAL DIAGNOSTICS
（その他企業）
・FUJIREBIO US, INC.
・ORASURE TECHNOLOGIES
・EPITOPE DIAGNOSTICS
・TRIVITRON HEALTHCARE
・MERIL LIFE SCIENCES PVT. LTD.
・GENMARK DIAGNOSTICS INC.
・VELA DIAGNOSTICS
・MOLBIO DIAGNOSTICS PVT. LTD.
・GENEOMBIO TECHNOLOGIES PVT. LTD.
・MEDMIRA INC.
（全175頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1.... INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY
1.3 MARKET SCOPE
・ FIGURE 1.................. HEPATITIS TESTING MARKET SEGMENTATION
1.3.1 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
2.... RESEARCH METHODOLOGY
2.1 RESEARCH DATA
・ FIGURE 2.................................................. RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 SECONDARY SOURCES
2.1.2 PRIMARY DATA
・ FIGURE 3.................................................. PRIMARY SOURCES
2.1.2.1 KEY INDUSTRY INSIGHTS
・ FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
・ FIGURE 5......... MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.2.1 GROWTH FORECAST
・ FIGURE 6................. CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
・ FIGURE 7.............................................. TOP-DOWN APPROACH
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
・ FIGURE 8.......................... DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ANALYSIS
2.5 ASSUMPTIONS FOR THE STUDY
2.5.1 COVID-19-SPECIFIC ASSUMPTIONS
2.6 LIMITATIONS
2.7 RISK ASSESSMENT
2.8 COVID-19 ECONOMIC ASSESSMENT
2.9 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
・ FIGURE 9................. CRITERIA IMPACTING THE GLOBAL ECONOMY
・ FIGURE 10........... RECOVERY SCENARIO OF THE GLOBAL ECONOMY
3.... EXECUTIVE SUMMARY
・ FIGURE 11.............. HEPATITIS TESTING MARKET, BY DISEASE TYPE,
2021 VS. 2026 (USD MILLION)
・ FIGURE 12.............. HEPATITIS TESTING MARKET, BY TECHNOLOGY,
2021 VS. 2026 (USD MILLION)
・ FIGURE 13...... HEPATITIS TESTING MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
・ FIGURE 14. HEPATITIS TESTING MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)
4.... PREMIUM INSIGHTS
4.1 HEPATITIS TESTING MARKET OVERVIEW
・ FIGURE 15. HIGH BURDEN OF HEPATITIS TO DRIVE MARKET GROWTH
4.2 HEPATITIS TESTING MARKET, BY TECHNOLOGY (2021–2026)
・ FIGURE 16.... RAPID DIAGNOSTIC TESTS SEGMENT TO REGISTER THE HIGHEST
CAGR DURING THE FORECAST PERIOD
4.3 NORTH AMERICA: HEPATITIS TESTING MARKET, BY DISEASE TYPE AND COUNTRY (2020)
・ FIGURE 17..... THE US ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH
AMERICAN HEPATITIS TESTING MARKET IN 2020
4.4 HEPATITIS TESTING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
・ FIGURE 18......... ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH DURING
THE FORECAST PERIOD
5.... MARKET OVERVIEW
5.1 INTRODUCTION
・ FIGURE 19...... HEPATITIS TESTING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 HIGH BURDEN OF HEPATITIS
・ TABLE 1......... HEPATITIS PREVALENCE, BY REGION, 2019 (MILLION)
5.2.1.2 INCREASING BLOOD TRANSFUSION AND DONATIONS
・ TABLE 2.. AVERAGE PREVALENCE OF HEPATITIS INFECTION IN BLOOD DONATIONS,
BY INCOME GROUP
5.2.1.3 BENEFITS OF POC INSTRUMENTS AND KITS
5.2.1.4 AWARENESS INITIATIVES ON HEPATITIS
5.2.2 RESTRAINTS
5.2.2.1 HIGH COST OF NUCLEIC ACID TESTS
5.2.2.2 LACK OF MANDATES FOR NUCLEIC ACID TESTS IN DEVELOPING COUNTRIES.. 51
5.2.2.3 UNFAVORABLE REIMBURSEMENT SCENARIO
5.2.3 OPPORTUNITIES
5.2.3.1 EMERGING MARKETS
5.2.3.2 RISING TECHNOLOGICAL ADVANCEMENTS IN MOLECULAR DIAGNOSTICS
5.2.3.3 GROWTH IN THE BIOTECHNOLOGY AND BIOPHARMACEUTICAL INDUSTRIES
5.2.4 CHALLENGES
5.2.4.1 CHANGING REGULATORY LANDSCAPE
5.2.4.2 OPERATIONAL BARRIERS
5.2.4.3 SHORTAGE OF SKILLED PROFESSIONALS
5.3 COVID-19 IMPACT ON THE HEPATITIS TESTING MARKET
6.... HEPATITIS TESTING MARKET, BY DISEASE TYPE
6.1 INTRODUCTION
・ TABLE 3. HEPATITIS TESTING MARKET, BY DISEASE TYPE, 2018–2020 (USD MILLION)
・ TABLE 4. HEPATITIS TESTING MARKET, BY DISEASE TYPE, 2021–2026 (USD MILLION)
6.2 HEPATITIS B (HBV)
6.2.1 HEPATITIS B SEGMENT TO HOLD THE LARGEST MARKET SHARE DURING
THE FORECAST PERIOD
・ TABLE 5 HEPATITIS B CHRONIC INFECTIONS IN THE WESTERN PACIFIC REGION, 2019
・ TABLE 6...... HEPATITIS B TESTING MARKET, BY REGION, 2018–2020 (USD MILLION)
・ TABLE 7...... HEPATITIS B TESTING MARKET, BY REGION, 2021–2026 (USD MILLION)
・ TABLE 8........... NORTH AMERICA: HEPATITIS B TESTING MARKET, BY COUNTRY,
2018–2020 (USD MILLION)
・ TABLE 9........... NORTH AMERICA: HEPATITIS B TESTING MARKET, BY COUNTRY,
2021–2026 (USD MILLION)
・ TABLE 10...... EUROPE: HEPATITIS B TESTING MARKET, BY COUNTRY,
2018–2020 (USD MILLION)
・ TABLE 11...... EUROPE: HEPATITIS B TESTING MARKET, BY COUNTRY,
2021–2026 (USD MILLION)
6.3 HEPATITIS C (HCV)
6.3.1 GOVERNMENT INITIATIVES FOR SUPPORTING HCV DIAGNOSIS
TO DRIVE MARKET GROWTH
・ TABLE 12......... HEPATITIS C CHRONIC INFECTIONS IN THE WESTERN PACIFIC REGION, 2019
・ TABLE 13.... HEPATITIS C TESTING MARKET, BY REGION, 2018–2020 (USD MILLION)
・ TABLE 14.... HEPATITIS C TESTING MARKET, BY REGION, 2021–2026 (USD MILLION)
・ TABLE 15......... NORTH AMERICA: HEPATITIS C TESTING MARKET, BY COUNTRY,
2018–2020 (USD MILLION)
・ TABLE 16......... NORTH AMERICA: HEPATITIS C TESTING MARKET, BY COUNTRY,
2021–2026 (USD MILLION)
・ TABLE 17...... EUROPE: HEPATITIS C TESTING MARKET, BY COUNTRY,
2018–2020 (USD MILLION)
・ TABLE 18...... EUROPE: HEPATITIS C TESTING MARKET, BY COUNTRY,
2021–2026 (USD MILLION)
6.4 OTHER HEPATITIS DISEASES
・ TABLE 19....... REP0RTED HEPATITIS A CASES IN THE US SINCE 2016
・ TABLE 20.. OTHER HEPATITIS DISEASE TESTING MARKET, BY REGION,
2018–2020 (USD MILLION)
・ TABLE 21.. OTHER HEPATITIS DISEASE TESTING MARKET, BY REGION,
2021–2026 (USD MILLION)
・ TABLE 22....... NORTH AMERICA: OTHER HEPATITIS DISEASE TESTING MARKET,
BY COUNTRY, 2018–2020 (USD MILLION)
・ TABLE 23....... NORTH AMERICA: OTHER HEPATITIS DISEASE TESTING MARKET,
BY COUNTRY, 2021–2026 (USD MILLION)
・ TABLE 24.. EUROPE: OTHER HEPATITIS DISEASE TESTING MARKET, BY COUNTRY,
2018–2020 (USD MILLION)
・ TABLE 25.. EUROPE: OTHER HEPATITIS DISEASE TESTING MARKET, BY COUNTRY,
2021–2026 (USD MILLION)
7.... HEPATITIS TESTING MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
・ TABLE 26 HEPATITIS TESTING MARKET, BY TECHNOLOGY, 2018–2020 (USD MILLION)
・ TABLE 27 HEPATITIS TESTING MARKET, BY TECHNOLOGY, 2021–2026 (USD MILLION)
7.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)
7.2.1 ELISA IS WIDELY USED FOR THE DETECTION OF HEPATITIS
・ TABLE 28......... HEPATITIS TESTING MARKET FOR ELISA, BY REGION,
2018–2020 (USD MILLION)
・ TABLE 29......... HEPATITIS TESTING MARKET FOR ELISA, BY REGION,
2021–2026 (USD MILLION)
・ TABLE 30.. NORTH AMERICA: HEPATITIS TESTING MARKET FOR ELISA, BY COUNTRY, 2018–2020 (USD MILLION)
・ TABLE 31.. NORTH AMERICA: HEPATITIS TESTING MARKET FOR ELISA, BY COUNTRY, 2021–2026 (USD MILLION)
・ TABLE 32......... EUROPE: HEPATITIS TESTING MARKET FOR ELISA, BY COUNTRY,
2018–2020 (USD MILLION)
・ TABLE 33......... EUROPE: HEPATITIS TESTING MARKET FOR ELISA, BY COUNTRY,
2021–2026 (USD MILLION)
7.3 RAPID DIAGNOSTIC TESTS (RDT)
7.3.1 RAPID TESTS ARE HIGHLY USEFUL IN COUNTRIES WITH LIMITED ACCESSIBILITY TO SOPHISTICATED TECHNOLOGIES
・ TABLE 34........ HEPATITIS TESTING MARKET FOR RAPID DIAGNOSTIC TESTS, BY REGION, 2018–2020 (USD MILLION)
・ TABLE 35........ HEPATITIS TESTING MARKET FOR RAPID DIAGNOSTIC TESTS, BY REGION, 2021–2026 (USD MILLION)
・ TABLE 36. NORTH AMERICA: HEPATITIS TESTING MARKET FOR RAPID DIAGNOSTIC TESTS, BY COUNTRY, 2018–2020 (USD MILLION)
・ TABLE 37. NORTH AMERICA: HEPATITIS TESTING MARKET FOR RAPID DIAGNOSTIC TESTS, BY COUNTRY, 2021–2026 (USD MILLION)
・ TABLE 38............. EUROPE: HEPATITIS TESTING MARKET FOR RAPID DIAGNOSTIC TESTS,
BY COUNTRY, 2018–2020 (USD MILLION)
・ TABLE 39............. EUROPE: HEPATITIS TESTING MARKET FOR RAPID DIAGNOSTIC TESTS,
BY COUNTRY, 2021–2026 (USD MILLION)
7.4 POLYMERASE CHAIN REACTION (PCR)
7.4.1 PCR TECHNOLOGY IS USED IN CONFIRMATORY TESTS FOR
HEPATITIS DIAGNOSIS
・ TABLE 40...... HEPATITIS TESTING MARKET FOR POLYMERASE CHAIN REACTION,
BY REGION, 2018–2020 (USD MILLION)
・ TABLE 41...... HEPATITIS TESTING MARKET FOR POLYMERASE CHAIN REACTION,
BY REGION, 2021–2026 (USD MILLION)
・ TABLE 42.......... NORTH AMERICA: HEPATITIS TESTING MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2018–2020 (USD MILLION)
・ TABLE 43.......... NORTH AMERICA: HEPATITIS TESTING MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2021–2026 (USD MILLION)
・ TABLE 44... EUROPE: HEPATITIS TESTING MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2018–2020 (USD MILLION)
・ TABLE 45... EUROPE: HEPATITIS TESTING MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2021–2026 (USD MILLION)
7.5 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT)
7.5.1 COST-BENEFITS OF INAAT ARE DRIVING THE GROWTH OF THIS MARKET SEGMENT
・ TABLE 46......... HEPATITIS TESTING MARKET FOR INAAT, BY REGION,
2018–2020 (USD MILLION)
・ TABLE 47......... HEPATITIS TESTING MARKET FOR INAAT, BY REGION,
2021–2026 (USD MILLION)
・ TABLE 48. NORTH AMERICA: HEPATITIS TESTING MARKET FOR INAAT, BY COUNTRY, 2018–2020 (USD MILLION)
・ TABLE 49. NORTH AMERICA: HEPATITIS TESTING MARKET FOR INAAT, BY COUNTRY, 2021–2026 (USD MILLION)
・ TABLE 50......... EUROPE: HEPATITIS TESTING MARKET FOR INAAT, BY COUNTRY,
2018–2020 (USD MILLION)
・ TABLE 51......... EUROPE: HEPATITIS TESTING MARKET FOR INAAT, BY COUNTRY,
2021–2026 (USD MILLION)
7.6 OTHER TECHNOLOGIES
・ TABLE 52... HEPATITIS TESTING MARKET FOR OTHER TECHNOLOGIES, BY REGION,
2018–2020 (USD MILLION)
・ TABLE 53... HEPATITIS TESTING MARKET FOR OTHER TECHNOLOGIES, BY REGION,
2021–2026 (USD MILLION)
・ TABLE 54. NORTH AMERICA: HEPATITIS TESTING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2018–2020 (USD MILLION)
・ TABLE 55. NORTH AMERICA: HEPATITIS TESTING MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2026 (USD MILLION)
・ TABLE 56............ EUROPE: HEPATITIS TESTING MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2018–2020 (USD MILLION)
・ TABLE 57............ EUROPE: HEPATITIS TESTING MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY, 2021–2026 (USD MILLION)
8.... HEPATITIS TESTING MARKET, BY END USER
8.1 INTRODUCTION
・ TABLE 58.... HEPATITIS TESTING MARKET, BY END USER, 2018–2020 (USD MILLION)
・ TABLE 59.... HEPATITIS TESTING MARKET, BY END USER, 2021–2026 (USD MILLION)
8.2 HOSPITAL & DIAGNOSTIC LABORATORIES
8.2.1 HOSPITAL & DIAGNOSTIC LABORATORIES ARE THE LARGEST END USERS
OF HEPATITIS TESTING PRODUCTS
・ TABLE 60. HEPATITIS TESTING MARKET FOR HOSPITAL & DIAGNOSTIC LABORATORIES, BY REGION, 2018–2020 (USD MILLION)
・ TABLE 61. HEPATITIS TESTING MARKET FOR HOSPITAL & DIAGNOSTIC LABORATORIES, BY REGION, 2021–2026 (USD MILLION)
・ TABLE 62.......... NORTH AMERICA: HEPATITIS TESTING MARKET FOR HOSPITAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018–2020 (USD MILLION)
・ TABLE 63.......... NORTH AMERICA: HEPATITIS TESTING MARKET FOR HOSPITAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2026 (USD MILLION)
・ TABLE 64..... EUROPE: HEPATITIS TESTING MARKET FOR HOSPITAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018–2020 (USD MILLION)
・ TABLE 65..... EUROPE: HEPATITIS TESTING MARKET FOR HOSPITAL & DIAGNOSTIC LABORATORIES, BY COUNTRY, 2021–2026 (USD MILLION)
8.3 BLOOD BANKS
8.3.1 INCREASING NUMBER OF BLOOD DONATIONS TO DRIVE THE GROWTH
OF THIS MARKET SEGMENT
・ TABLE 66......... HEPATITIS TESTING MARKET FOR BLOOD BANKS, BY REGION,
2018–2020 (USD MILLION)
・ TABLE 67......... HEPATITIS TESTING MARKET FOR BLOOD BANKS, BY REGION,
2021–2026 (USD MILLION)
・ TABLE 68 NORTH AMERICA: HEPATITIS TESTING MARKET FOR BLOOD BANKS,
BY COUNTRY, 2018–2020 (USD MILLION)
・ TABLE 69 NORTH AMERICA: HEPATITIS TESTING MARKET FOR BLOOD BANKS,
BY COUNTRY, 2021–2026 (USD MILLION)
・ TABLE 70. EUROPE: HEPATITIS TESTING MARKET FOR BLOOD BANKS, BY COUNTRY, 2018–2020 (USD MILLION)
・ TABLE 71. EUROPE: HEPATITIS TESTING MARKET FOR BLOOD BANKS, BY COUNTRY, 2021–2026 (USD MILLION)
8.4 OTHER END USERS
・ TABLE 72.... HEPATITIS TESTING MARKET FOR OTHER END USERS, BY REGION,
2018–2020 (USD MILLION)
・ TABLE 73.... HEPATITIS TESTING MARKET FOR OTHER END USERS, BY REGION,
2021–2026 (USD MILLION)
・ TABLE 74. NORTH AMERICA: HEPATITIS TESTING MARKET FOR OTHER END USERS,
BY COUNTRY, 2018–2020 (USD MILLION)
・ TABLE 75. NORTH AMERICA: HEPATITIS TESTING MARKET FOR OTHER END USERS,
BY COUNTRY, 2021–2026 (USD MILLION)
・ TABLE 76...... EUROPE: HEPATITIS TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2018–2020 (USD MILLION)
・ TABLE 77...... EUROPE: HEPATITIS TESTING MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2026 (USD MILLION)
9.... HEPATITIS TESTING MARKET, BY REGION
9.1 INTRODUCTION
・ TABLE 78........... GLOBAL: HEPATITIS TESTING MARKET, BY REGION,
2018–2020 (USD MILLION)
・ TABLE 79........... GLOBAL: HEPATITIS TESTING MARKET, BY REGION,
2021–2026 (USD MILLION)
9.2 NORTH AMERICA
・ FIGURE 20 NORTH AMERICA: HEPATITIS TESTING MARKET SNAPSHOT
・ TABLE 80............ NORTH AMERICA: HEPATITIS TESTING MARKET, BY COUNTRY,
2018–2020 (USD MILLION)
・ TABLE 81............ NORTH AMERICA: HEPATITIS TESTING MARKET, BY COUNTRY,
2021–2026 (USD MILLION)
・ TABLE 82 NORTH AMERICA: HEPATITIS TESTING MARKET, BY DISEASE TYPE,
2018–2020 (USD MILLION)
・ TABLE 83 NORTH AMERICA: HEPATITIS TESTING MARKET, BY DISEASE TYPE,
2021–2026 (USD MILLION)
・ TABLE 84............ NORTH AMERICA: HEPATITIS TESTING MARKET, BY TECHNOLOGY,
2018–2020 (USD MILLION)
・ TABLE 85............ NORTH AMERICA: HEPATITIS TESTING MARKET, BY TECHNOLOGY,
2021–2026 (USD MILLION)
・ TABLE 86...... NORTH AMERICA: HEPATITIS TESTING MARKET, BY END USER,
2018–2020 (USD MILLION)
・ TABLE 87...... NORTH AMERICA: HEPATITIS TESTING MARKET, BY END USER,
2021–2026 (USD MILLION)
9.2.1 US
9.2.1.1 HIGH HEALTHCARE EXPENDITURE TO DRIVE MARKET GROWTH IN THE US.. 94
・ TABLE 88. US: NUMBER OF HEPATITIS A CASES REPORTED, 2015 VS. 2019
・ TABLE 89 HEPATITIS A PREVALENCE RATE PER 100,000 POPULATION
IN THE US, 2013–2017
・ TABLE 90....................................... US: KEY MACROINDICATORS
・ TABLE 91.......... US: HEPATITIS TESTING MARKET, BY DISEASE TYPE,
2018–2020 (USD MILLION)
・ TABLE 92.......... US: HEPATITIS TESTING MARKET, BY DISEASE TYPE,
2021–2026 (USD MILLION)
・ TABLE 93........... US: HEPATITIS TESTING MARKET, BY TECHNOLOGY,
2018–2020 (USD MILLION)
・ TABLE 94........... US: HEPATITIS TESTING MARKET, BY TECHNOLOGY,
2021–2026 (USD MILLION)
・ TABLE 95...... US: HEPATITIS TESTING MARKET, BY END USER, 2018–2020 (USD MILLION)
・ TABLE 96...... US: HEPATITIS TESTING MARKET, BY END USER, 2021–2026 (USD MILLION)
9.2.2 CANADA
9.2.2.1 FAVORABLE GOVERNMENT INITIATIVES ARE EXPECTED TO BOOST MARKET GROWTH IN CANADA
・ TABLE 97............................... CANADA: KEY MACROINDICATORS
・ TABLE 98... CANADA: HEPATITIS TESTING MARKET, BY DISEASE TYPE,
2018–2020 (USD MILLION)
・ TABLE 99... CANADA: HEPATITIS TESTING MARKET, BY DISEASE TYPE,
2021–2026 (USD MILLION)
・ TABLE 100.. CANADA: HEPATITIS TESTING MARKET, BY TECHNOLOGY,
2018–2020 (USD MILLION)
・ TABLE 101.. CANADA: HEPATITIS TESTING MARKET, BY TECHNOLOGY,
2021–2026 (USD MILLION)
・ TABLE 102...... CANADA: HEPATITIS TESTING MARKET, BY END USER,
2018–2020 (USD MILLION)
・ TABLE 103...... CANADA: HEPATITIS TESTING MARKET, BY END USER,
2021–2026 (USD MILLION)
9.3 EUROPE
・ TABLE 104 NUMBER OF HEPATITIS B CASES IN EUROPE, BY COUNTRY, 2014–2018
・ TABLE 105....... EUROPE: HEPATITIS TESTING MARKET, BY COUNTRY,
2018–2020 (USD MILLION)
・ TABLE 106....... EUROPE: HEPATITIS TESTING MARKET, BY COUNTRY,
2021–2026 (USD MILLION)
・ TABLE 107.. EUROPE: HEPATITIS TESTING MARKET, BY DISEASE TYPE,
2018–2020 (USD MILLION)
・ TABLE 108.. EUROPE: HEPATITIS TESTING MARKET, BY DISEASE TYPE,
2021–2026 (USD MILLION)
・ TABLE 109.. EUROPE: HEPATITIS TESTING MARKET, BY TECHNOLOGY,
2018–2020 (USD MILLION)
・ TABLE 110.. EUROPE: HEPATITIS TESTING MARKET, BY TECHNOLOGY,
2021–2026 (USD MILLION)
・ TABLE 111...... EUROPE: HEPATITIS TESTING MARKET, BY END USER,
2018–2020 (USD MILLION)
・ TABLE 112...... EUROPE: HEPATITIS TESTING MARKET, BY END USER,
2021–2026 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 INCREASING DEMAND FOR ADVANCED DIAGNOSTIC TECHNOLOGIES TO DRIVE MARKET GROWTH IN GERMANY
・ TABLE 113............................ GERMANY: KEY MACROINDICATORS
・ TABLE 114 GERMANY: HEPATITIS TESTING MARKET, BY DISEASE TYPE,
2018–2020 (USD MILLION)
・ TABLE 115 GERMANY: HEPATITIS TESTING MARKET, BY DISEASE TYPE,
2021–2026 (USD MILLION)
・ TABLE 116 GERMANY: HEPATITIS TESTING MARKET, BY TECHNOLOGY,
2018–2020 (USD MILLION)
・ TABLE 117 GERMANY: HEPATITIS TESTING MARKET, BY TECHNOLOGY,
2021–2026 (USD MILLION)
・ TABLE 118.... GERMANY: HEPATITIS TESTING MARKET, BY END USER,
2018–2020 (USD MILLION)
・ TABLE 119.... GERMANY: HEPATITIS TESTING MARKET, BY END USER,
2021–2026 (USD MILLION)
9.3.2 UK
9.3.2.1 INCREASING NUMBER OF CLINICAL LABORATORIES TO DRIVE MARKET
GROWTH IN THE UK
・ TABLE 120. NUMBER OF HEPATITIS C CASES REPORTED IN ENGLAND AND
WALES, 2008–2018
・ TABLE 121..................................... UK: KEY MACROINDICATORS
・ TABLE 122......... UK: HEPATITIS TESTING MARKET, BY DISEASE TYPE,
2018–2020 (USD MILLION)
・ TABLE 123......... UK: HEPATITIS TESTING MARKET, BY DISEASE TYPE,
2021–2026 (USD MILLION)
・ TABLE 124......... UK: HEPATITIS TESTING MARKET, BY TECHNOLOGY,
2018–2020 (USD MILLION)
・ TABLE 125......... UK: HEPATITIS TESTING MARKET, BY TECHNOLOGY,
2021–2026 (USD MILLION)
・ TABLE 126.... UK: HEPATITIS TESTING MARKET, BY END USER, 2018–2020 (USD MILLION)
・ TABLE 127.... UK: HEPATITIS TESTING MARKET, BY END USER, 2021–2026 (USD MILLION)
9.3.3 REST OF EUROPE
・ TABLE 128 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP)
・ TABLE 129....... ROE: HEPATITIS TESTING MARKET, BY DISEASE TYPE,
2018–2020 (USD MILLION)
・ TABLE 130....... ROE: HEPATITIS TESTING MARKET, BY DISEASE TYPE,
2021–2026 (USD MILLION)
・ TABLE 131....... ROE: HEPATITIS TESTING MARKET, BY TECHNOLOGY,
2018–2020 (USD MILLION)
・ TABLE 132....... ROE: HEPATITIS TESTING MARKET, BY TECHNOLOGY,
2021–2026 (USD MILLION)
・ TABLE 133........... ROE: HEPATITIS TESTING MARKET, BY END USER,
2018–2020 (USD MILLION)
・ TABLE 134........... ROE: HEPATITIS TESTING MARKET, BY END USER,
2021–2026 (USD MILLION)
9.4 ASIA PACIFIC
9.4.1 HIGH PREVALENCE OF HEPATITIS TO BOOST MARKET GROWTH
・ TABLE 135 ASIA PACIFIC: ESTIMATED PREVALENCE OF CHRONIC HBV AND HCV
・ TABLE 136.. ASIA PACIFIC: COST COVERAGE FOR THE DIAGNOSIS OF CHRONIC
VIRAL HEPATITIS
・ FIGURE 21.... ASIA PACIFIC: HEPATITIS TESTING MARKET SNAPSHOT
・ TABLE 137................................ CHINA: KEY MACROINDICATORS
・ TABLE 138................................ JAPAN: KEY MACROINDICATORS
・ TABLE 139................................. INDIA: KEY MACROINDICATORS
・ TABLE 140... ASIA PACIFIC: HEPATITIS TESTING MARKET, BY DISEASE TYPE,
2018–2020 (USD MILLION)
・ TABLE 141... ASIA PACIFIC: HEPATITIS TESTING MARKET, BY DISEASE TYPE,
2021–2026 (USD MILLION)
・ TABLE 142.............. ASIA PACIFIC: HEPATITIS TESTING MARKET, BY TECHNOLOGY,
2018–2020 (USD MILLION)
・ TABLE 143.............. ASIA PACIFIC: HEPATITIS TESTING MARKET, BY TECHNOLOGY,
2021–2026 (USD MILLION)
・ TABLE 144 ASIA PACIFIC: HEPATITIS TESTING MARKET, BY END USER,
2018–2020 (USD MILLION)
・ TABLE 145 ASIA PACIFIC: HEPATITIS TESTING MARKET, BY END USER,
2021–2026 (USD MILLION)
9.5 REST OF THE WORLD
9.5.1 LESS-STRINGENT REGULATIONS FOR DIAGNOSTIC PRODUCTS TO DRIVE MARKET GROWTH
・ TABLE 146..... REST OF THE WORLD: HEPATITIS TESTING MARKET, BY DISEASE TYPE,
2018–2020 (USD MILLION)
・ TABLE 147..... REST OF THE WORLD: HEPATITIS TESTING MARKET, BY DISEASE TYPE,
2021–2026 (USD MILLION)
・ TABLE 148..... REST OF THE WORLD: HEPATITIS TESTING MARKET, BY TECHNOLOGY,
2018–2020 (USD MILLION)
・ TABLE 149..... REST OF THE WORLD: HEPATITIS TESTING MARKET, BY TECHNOLOGY,
2021–2026 (USD MILLION)
・ TABLE 150 REST OF THE WORLD: HEPATITIS TESTING MARKET, BY END USER,
2018–2020 (USD MILLION)
・ TABLE 151 REST OF THE WORLD: HEPATITIS TESTING MARKET, BY END USER,
2021–2026 (USD MILLION)
10.. COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
・ TABLE 152.... OVERVIEW OF STRATEGIES ADOPTED BY KEY HEPATITIS TESTING
MARKET PLAYERS
10.3 MARKET SHARE ANALYSIS
・ FIGURE 22...... HEPATITIS TESTING MARKET SHARE ANALYSIS, 2020
・ TABLE 153... HEPATITIS TESTING MARKET: DEGREE OF COMPETITION (2020)
10.4 COMPANY EVALUATION QUADRANT
10.4.1 STARS
10.4.2 EMERGING LEADERS.. 126
10.4.3 PERVASIVE PLAYERS.. 126
10.4.4 PARTICIPANTS
・ FIGURE 23...... HEPATITIS TESTING MARKET: COMPANY EVALUATION QUADRANT (2020)
10.5 COMPANY EVALUATION QUADRANT: SMES/START-UPS
10.5.1 PROGRESSIVE COMPANIES
10.5.2 STARTING BLOCKS.. 128
10.5.3 RESPONSIVE COMPANIES
10.5.4 DYNAMIC COMPANIES.. 128
・ FIGURE 24...... HEPATITIS TESTING MARKET: COMPANY EVALUATION QUADRANT
FOR SMES & START-UPS (2020)
10.6 COMPETITIVE SCENARIO.. 129
10.6.1 PRODUCT LAUNCHES & APPROVALS
・ TABLE 154........................... PRODUCT LAUNCHES & APPROVALS
10.6.2 DEALS
・ TABLE 155.................................................................. DEALS
10.6.3 OTHER DEVELOPMENTS
・ TABLE 156........................................... OTHER DEVELOPMENTS
10.7 COMPANY FOOTPRINT ANALYSIS
・ TABLE 157 TECHNOLOGY, DISEASE TYPE, AND REGIONAL FOOTPRINT OF COMPANIES
・ TABLE 158.................... TECHNOLOGY FOOTPRINT OF COMPANIES
・ TABLE 159.................... DISEASE TYPE FOOTPRINT OF COMPANIES
・ TABLE 160........................ REGIONAL FOOTPRINT OF COMPANIES
11.. COMPANY PROFILE
11.1 KEY PLAYERS
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, DEALS, MNM VIEW, KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, WEAKNESS/COMPETITIVE THREATS)*
11.1.1 ABBOTT LABORATORIES
・ TABLE 161.............. ABBOTT LABORATORIES: BUSINESS OVERVIEW
・ FIGURE 25.... ABBOTT LABORATORIES: COMPANY SNAPSHOT (2020)
11.1.2 F. HOFFMANN-LA ROCHE LTD.
・ TABLE 162...... F. HOFFMANN-LA ROCHE LTD.: BUSINESS OVERVIEW
・ FIGURE 26...... F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2020)
11.1.3 BIO-RAD LABORATORIES, INC.
・ TABLE 163...... BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
・ FIGURE 27..... BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2020)
11.1.4 SIEMENS HEALTHINEERS AG
・ TABLE 164........ SIEMENS HEALTHINEERS AG: BUSINESS OVERVIEW
・ FIGURE 28....... SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2020)
11.1.5 DIASORIN S.P.A
・ TABLE 165........................ DIASORIN S.P.A: BUSINESS OVERVIEW
・ FIGURE 29............. DIASORIN S.P.A.: COMPANY SNAPSHOT (2020)
11.1.6 QIAGEN
・ TABLE 166................................... QIAGEN: BUSINESS OVERVIEW
・ FIGURE 30........................ QIAGEN: COMPANY SNAPSHOT (2020)
11.1.7 DANAHER CORPORATION
・ TABLE 167............ DANAHER CORPORATION: BUSINESS OVERVIEW
・ FIGURE 31.. DANAHER CORPORATION: COMPANY SNAPSHOT (2020)
11.1.8 GRIFOLS, S.A.
・ TABLE 168........................... GRIFOLS, S.A.: BUSINESS OVERVIEW
・ FIGURE 32................ GRIFOLS, S.A.: COMPANY SNAPSHOT (2020)
11.1.9 BIOMÉRIEUX SA
・ TABLE 169........................ BIOMÉRIEUX SA: BUSINESS OVERVIEW
・ FIGURE 33.............. BIOMÉRIEUX SA: COMPANY SNAPSHOT (2020)
11.1.10 ORTHO CLINICAL DIAGNOSTICS.. 162
・ TABLE 170.... ORTHO CLINICAL DIAGNOSTICS: BUSINESS OVERVIEW
・ FIGURE 34.... ORTHO CLINICAL DIAGNOSTICS: COMPANY SNAPSHOT (2020)
11.2 OTHER PLAYERS
11.2.1 FUJIREBIO US, INC.
11.2.2 ORASURE TECHNOLOGIES
11.2.3 EPITOPE DIAGNOSTICS
11.2.4 TRIVITRON HEALTHCARE
11.2.5 MERIL LIFE SCIENCES PVT. LTD.
11.2.6 GENMARK DIAGNOSTICS INC.
11.2.7 VELA DIAGNOSTICS.. 170
11.2.8 MOLBIO DIAGNOSTICS PVT. LTD.
11.2.9 GENEOMBIO TECHNOLOGIES PVT. LTD.
11.2.10 MEDMIRA INC.
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, DEALS, MNM VIEW, KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, WEAKNESS/COMPETITIVE THREATS MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
12.. APPENDIX